An anesthesiologist at the University of Alabama at Birmingham Hospital was one of six physicians in the country to receive the Lathem Physician Leadership Award in Hand Hygiene from Proventix Systems of Birmingham.
Anesthesia
Two physicians from the department of anesthesiology and perioperative care at the University of California at Irvine have received Foundation of Anesthesia, Education and Research grants. Both anesthesiologists will receive a two-year grant supported by the American Society of Anesthesiologists.
The University of Pittsburgh has named Debra K. Weiner, MD, director of a new pain center established under the National Institutes of Health Pain Consortium.
The American Board of Anesthesiology has appointed Jill Mhyre, MD, of the University of Michigan Health System, to the position of senior editor for the Joint Council on Anesthesiology Examinations.
The U.S. House of Representatives passed legislation last week that reauthorized the FDA drug and medical device review process, according to an ASC Association release.
Advertisement
Editor's note: This article by Tony Mira, president and CEO of Anesthesia Business Consultants, an anesthesia & pain management billing and practice management services company, originally appeared in Anesthesia Business Consultants eAlerts, a free electronic newsletter. Sign-up to receive this…
The department of anesthesiology at the University of Maryland School of Medicine in Baltimore last week announced a new regional anesthesiology fellowship program.
ETView Medical today appointed David Amar, MD, to its scientific advisory board. Dr. Amar will work with the device company to advance the development of surgical lung isolation products.
Two proposed arrangements between anesthesiologists and physician-owned facilities could lead to administrative sanctions, according to a Department of Health and Human Services Office of Inspector General release.
The U.S. House of Representatives yesterday passed the Prescription Drug User Fee Act reauthorization, a legislative package that includes an FDA provision to prevent and mitigate national drug shortages.